Listeria monocytogenes has emerged as a remarkably tractable pathogen to dissect basic aspects of cell biology, intracellular pathogenesis, and innate and acquired immunity. In order to maintain its intracellular lifestyle, L. monocytogenes has evolved a number of mechanisms to exploit host processes to grow and spread cell to cell without damaging the host cell. The pore-forming protein listeriolysin O mediates escape from host vacuoles and utilizes multiple fail-safe mechanisms to avoid causing toxicity to infected cells. Once in the cytosol, the L. monocytogenes ActA protein recruits host cell Arp2/3 complexes and enabled/vasodilator-stimulated phosphoprotein family members to mediate efficient actin-based motility, thereby propelling the bacteria into neighboring cells. Alteration in any of these processes dramatically reduces the ability of the bacteria to establish a productive infection in vivo.
Natural history and murine listeriosis model
Listeria monocytogenes is an ubiquitous, rapidly growing, Gram-positive bacterium with an unusually broad ecological niche and host range. Infection of humans and animals has been traced to contaminated foods and can lead to serious, often fatal disease. In humans, disease is most common among pregnant women, newborns, and immunocompromised individuals (Schlech, 2000).
Murine listeriosis has been studied for the past four decades to examine basic aspects of innate and acquired cellular immunity (North et al., 1997; Unanue, 1997; Finelli and Pamer, 2000; Harty et al., 2000). Critical features of the murine model are that it is relatively rapid and quantitative, either by enumeration of colony forming units in the liver and spleen or by determination of a lethal dose. During experimental listeriosis, laboratory-grown bacteria are commonly injected in the tail vein and internalized by liver and splenic macrophages. In the liver, the majority of bacteria are killed by resident macrophages. Surviving bacteria grow in macrophages and spread into hepatocytes and form foci of infection that attract the influx of neutrophils and activated macrophages and resolve as granulomas. Mice that survive a sublethal dose of live bacteria acquire enhanced resistance to subsequent challenge. Acquired immunity is entirely cell mediated and largely dependent on cytotoxic CD8+ T-cells that recognize and lyse infected cells. Antibodies play little or no role in immunity, and administration of killed bacteria does not induce protective immunity, an observation with obvious implications for the development of vaccines to intracellular pathogens.
In vitro models of listeriosis
L. monocytogenes is particularly amenable to in vitro models of infection, as it enters and grows rapidly in a wide variety of tissue culture cells. However, as a facultative pathogen, it also grows in tissue culture media. To prevent extracellular replication, the aminoglycoside antibiotic gentamicin is added to infected cells subsequent to bacterial internalization. A relatively high concentration of gentamicin is bactericidal for extracellular bacteria, but has no measurable effect on intracellular wild-type L. monocytogenes during the first 8 h of infection (Brundage et al., 1993). Intracellular L. monocytogenes grow with initial doubling times of ∼40 min, which approximates the growth rate in rich media. Importantly, in most cells, intracellular growth continues without causing damage to host cells and, as will be discussed below, mutants that prematurely kill or damage host cells are avirulent. However, whereas cells infected with wild-type bacteria eventually die sometime after 8 h postinfection, bacteria rapidly spread to neighboring cells and thus propagate the infection (Fig. 1). Intracellular growth and cell-to-cell spread can be quantitated by measuring the diameter of macroscopic plaques that form in monolayers of cells. Plaque size has proven to be a good correlate of in vivo virulence (Marquis et al., 1997).
L. monocytogenes enters almost all adherent cells, but the efficiency of uptake can vary over 10,000-fold. Macrophages and macrophage-like cell lines can internalize up to 20 bacteria per cell, whereas fibroblast cell lines internalize less than one bacterium per cell. However, significant levels of internalization by nonprofessional phagocytic cells is often mediated by one or more bacterial surface proteins, collectively named internalins, of which Internalin A and B are the best characterized (Braun and Cossart, 2000). Internalin A promotes binding and internalization by E-cadherin, whereas Internalin B binds to the Met receptor tyrosine kinase and mediates internalization via PI3-kinase activation (Cossart, 2001). The remainder of this review will focus on events that occur subsequent to internalization.
Escape from a vacuole
Upon phagocytosis by macrophages, there are a number of possible fates awaiting a bacterium (Duclos and Desjardins, 2000). In the case of L. monocytogenes, internalized bacteria are either killed or escape into the cytosol. Mutants that fail to escape from a vacuole may survive in tissue culture cell lines, but do not grow. The pore-forming protein listeriolysin O (LLO)* is largely responsible for mediating escape from the vacuole, and is consequently an essential determinant of pathogenicity (Vazquez-Boland et al., 2001). Mutants lacking LLO fail to escape from a vacuole in most cells, and synthesis of LLO by other organisms such as Bacillus subtilis is sufficient to mediate escape from a vacuole (Bielecki et al., 1990). Thus, it is clear that the role of LLO is to mediate vacuolar escape from a phagosome and from a secondary vacuole formed upon cell-to-cell spread (Gedde et al., 2000).
In addition to LLO, L. monocytogenes secretes two phospholipases C (PLCs) that contribute to escape: a phosphatidylinositol-specific PLC (PI-PLC) and a broad-spectrum PLC (PC-PLC) that is synthesized as a proenzyme activated by a secreted L. monocytogenes metalloprotease (Vazquez-Boland et al., 2001). Mutants lacking both PLCs show a marked defect in vacuolar escape, and in human epithelial cells such as HeLa cells, PC-PLC and metalloprotease mediate escape from a vacuole in the absence of LLO (Marquis et al., 1995).
The precise mechanism by which L. monocytogenes escapes from a vacuole is not clear but is consistent with the following model: upon phagocytosis, the L. monocytogenes–containing vacuole acquires markers of a maturing endosome/phagosome and acidifies to an average pH of 5.9 (Alvarez-Dominguez et al., 1997; Beauregard et al., 1997). Agents, such as bafilomycin that block acidification, inhibit vacuolar perforation and bacterial escape (Conte et al., 1996; Beauregard et al., 1997; Glomski et al., 2002). We propose that LLO insertion into the phagosomal membrane has two functions: one is to dissipate the pH gradient and thereby halt the maturation of the phagosome, and the other is act as a channel for the passage of proteins from the vacuole. The bacterial phospholipases and/or host vacuolar constituents then pass through the channel and act on the vacuole, leading to its dissolution. A direct role played by the host cell, if any, in mediating vacuolar dissolution is yet to be appreciated, although a host protease can activate PC-PLC during cell-to-cell spread (Marquis et al., 1997).
Compartmentalization of LLO activity
LLO is one of 22 members of the cholesterol-dependent family of cytolysins (CDCs) secreted by Gram-positive bacteria (Tweten et al., 2001). The best characterized of the CDCs are perfringolysin O (PFO) and streptolysin O, which are normally secreted by extracellular pathogens and presumably act on cells from outside. Replacement of LLO with PFO in L. monocytogenes results in a strain that is able to escape from a vacuole, albeit at a reduced efficiency, but that kills the infected cells from within (Jones and Portnoy, 1994). Thus, LLO is apparently unique in that it acts in a vacuole, but does not kill the host cell upon growth in the cytosol. The properties of LLO as a vacuole-specific lysin can be exploited to deliver macromolecules to the cytosol of macrophages either by incorporation of LLO into acid sensitive liposomes or by expression of recombinant proteins in Escherichia coli expressing LLO (Lee et al., 1996; Higgins et al., 1999).
One unique feature of LLO that contributes to its lack of toxicity is a PEST-like sequence near its NH2 terminus, rich in proline, glutamate, serine, and threonine residues (Fig. 2) (Decatur and Portnoy, 2000; Lety et al., 2001). Removal of the PEST-like sequence does not affect LLO activity or vacuolar escape, but results in a strain that is extremely toxic to infected host cells and is 10,000-fold less virulent in mice. During in vitro infection, bacteria expressing the PEST-minus LLO permeabilize the host cell membrane after several bacterial generations, resulting in the influx of gentamicin and killing of the intracellular bacteria. Interestingly, most of the infected host cells apparently repair the LLO-mediated lesion and survive. In contrast, in the absence of gentamicin, intracellular PEST-minus bacteria continue to grow intracellularly and cause the rapid necrotic death of the infected host. Although it is tempting to assume that the PEST-like sequence is acting by targeting LLO for proteolytic degradation, the actual mechanism by which the PEST-like sequence acts to negate LLO toxicity is still not clear. However, the presence of three consensus mitogen-activated protein kinase sites (Fig. 2) suggests that it may be acting by interaction with host kinases. Mutation of the predicted phosphate acceptor residues results in a strain that is toxic to host cells and 100-fold less virulent (Decatur and Portnoy, 2000).
LLO is unique among the CDCs in that it has a pronounced acidic pH optimum. Mutation of a single LLO residue (L461T) results in an increase in LLO activity at neutral pH and leads to a 100-fold loss in virulence (Glomski et al., 2002). This mutation does not affect escape of L. monocytogenes from a vacuole, but causes premature permeabilization of infected host cells after about five bacterial generations. Thus, the acidic pH optimum of LLO, similar to the PEST-like sequence, restricts LLO activity to a vacuolar compartment.
Surprisingly, transcription and synthesis of LLO continues in the host cytosol (Bubert et al., 1999; Moors et al., 1999). However, a number of other potential mechanisms may be in place to prevent toxicity to the infected host. For example, PC-PLC secretion is acid dependent and occurs preferentially in host vacuoles (Marquis and Hager, 2000), although this is yet to be documented for LLO. Another intriguing observation is that LLO contains a consensus dipartite nuclear localization signal (Fig. 2). Although it has not been examined experimentally, shuttling of LLO to the nucleus, which has very little membrane cholesterol, would be yet another mechanism to prevent LLO from breaching the cytoplasmic membrane. Clearly, a molecule as potentially toxic as LLO has multiple regulatory mechanisms to prevent damage to host cells.
Growth in the cytosol
Intracellular pathogens can be broadly divided into those that grow within a modified vacuole of the host cell (Duclos and Desjardins, 2000) and those like L. monocytogenes that grow in the host cytosol. There is compelling evidence to suggest that the cytosol is a favorable environment for bacterial growth: Bacillus subtilis expressing LLO or E. coli precoated with LLO can escape from a vacuole and grow in the cytosol of tissue culture cell lines (Bielecki et al., 1990; Monack and Theriot, 2001). However, it was recently shown that an L. monocytogenes hexose phosphate transporter was virulence-regulated and necessary for growth on glucose-6-phosphate and optimal cytosolic growth (Chico-Calero et al., 2002). Thus, although nonpathogens can grow in the cytosol under some circumstances, intracytosolic bacteria have clearly evolved specific mechanisms to enhance intracellular growth. In addition, as discussed below for L. monocytogenes, most intracytosolic bacterial pathogens have evolved mechanisms of actin-based motility to spread from cell to cell (Goldberg, 2001). For a more detailed discussion of factors affecting cytosolic growth, see O'Riordan and Portnoy (2002).
Shortly after entry into the mammalian cytosol, L. monocytogenes induces the polymerization of host actin filaments and uses the force generated by actin polymerization to move, first intracellularly and then from cell to cell (Fig. 1; for video images, see: http://cmgm.stanford.edu/theriot/movies.htm). Remarkably, a single bacterial protein, ActA, is responsible for mediating actin nucleation, actin-based motility, and is necessary for pathogenicity. ActA-minus mutants escape normally from vacuoles, but grow in the host cytosol as microcolonies and do not spread cell to cell or form plaques in tissue culture cell monolayers. The ActA protein provides multiple binding sites for host cytoskeletal components, thereby acting as a scaffold to assemble the cell's actin polymerization machinery (Cameron et al., 2000). The NH2 terminus of ActA binds to monomeric actin and acts as a constitutively active nucleation promoting factor by stimulating the intrinsic actin nucleation activity of the Arp2/3 complex by a mechanism similar to that proposed for host WASP family proteins (Welch et al., 1998; Pistor et al., 2000; Skoble et al., 2000; Boujemaa-Paterski et al., 2001; Zalevsky et al., 2001). Although ActA and WASP family proteins share little overall amino acid similarity, they do share a region that binds the Arp2/3 complex, referred to as the connector sequence that spans 15 residues containing the core sequence KKRRK. Mutations in this site confer an ActA-null phenotype in cells (Pistor et al., 2000; Skoble et al., 2000; Boujemaa-Paterski et al., 2001; Lauer et al., 2001). ActA and WASP family proteins also share similarity in a short acidic stretch and both contain an actin binding region (WH2 region in WASP family proteins) that is unrelated.
The central region of ActA consists of three or four proline-rich repeats (consensus DFPPPPTDEEL) that bind the enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homology (EVH)1 domain of Ena/VASP family members with an affinity higher than that of all known EVH1 ligands such as vinculin and zyxin (Prehoda et al., 1999). Ena/VASP family members are important for many actin-based processes including cell motility, platelet shape change, axon guidance, and T-cell activation (Renfranz and Beckerle, 2002); however, a clear picture of their mechanistic role has yet to emerge. L. monocytogenes expressing ActA lacking Ena/VASP binding sites move more slowly in cells (Lasa et al., 1995; Smith et al., 1996), and wild-type L. monocytogenes fail to move at all in cells microinjected with an excess of EVH1-binding peptides (Southwick and Purich, 1994). Paradoxically, fibroblasts lacking Ena/VASP proteins crawl faster than cells expressing Mena (mouse Ena) (Bear et al., 2000). Ena/VASP proteins contain a proline-rich domain that binds profilin and an EVH2 domain that interacts with F-actin. Profilin specifically binds ATP monomeric actin and promotes actin polymerization from the barbed end of actin filaments (Pantaloni et al., 2001). Cells expressing Mena/VASP derivatives lacking profilin binding exhibit a decreased rate of L. monocytogenes motility but exhibit normal rates of cellular motility. In contrast, cells expressing Mena/VASP derivatives lacking the F-actin binding site move more rapidly than cells expressing wild-type Mena and support faster than wild-type rates of L. monocytogenes movement (Geese et al., 2002; Loureiro et al., 2002). However, in these cells, bacterial movement shows a significant difference in the directional persistence of actin-based motility resulting in less successful interaction with the cellular membrane and a corresponding decrease in plaque size (unpublished data). An explanation for these observations may be that Ena/VASP proteins, via their F-actin binding site, interact with the barbed ends of actin filaments and delay F-actin capping, resulting in longer, less branched actin filaments in vivo (Bear et al., 2002) and in vitro (Skoble et al., 2001). Thus, the role of Ena/VASP proteins is to augment actin polymerization and to regulate the architecture of the actin filament network (Fig. 3). A possible explanation for Ena/VASP's effect on branching may relate to a recent paper showing that the Arp2/3 complex displays a branching preference at or near the barbed end (Ichetovkin et al., 2002). Perhaps Ena/VASP's interaction with F-actin decreases the likelihood of Arp2/3-mediated branching.
One of the most striking results from the studies described above is that mutations in LLO that render strains prematurely cytotoxic are avirulent. Thus, just as it is commonly stated that successful pathogens have evolved to avoid killing their host, it is not beneficial for intracellular pathogens to kill their host cell. Indeed, the host has evolved innate and acquired mechanisms, including induction of apoptosis and the generation of antigen-specific cytotoxic T-cells, that result in killing of infected cells (Harty et al., 2000). Lysis by cytotoxic T-cells is an important acquired immunological effector mechanism to eliminate L. monocytogenes (Finelli and Pamer, 2000). This may provide an explanation for the observations that L. monocytogenes cytotoxic mutants are avirulent: premature killing of infected host cells may lead to extracellular bacteria that are readily killed by infiltrating phagocytes. This also provides a framework with which to understand why L. monocytogenes spreads from cell to cell; i.e., to avoid cytotoxic T-cells and phagocytes. Consistent with this notion, L. monocytogenes mutants that cannot recruit Ena/VASP peoteins show a small virulence defect in naïve mice, but show a 400-fold virulence defect in the liver of immune mice (Auerbuch et al., 2001) and (unpublished data). Presumably, efficient cell-to-cell spread is necessary during a cellular immune response. Lastly, it should be noted that an immunodominant epitope recognized by Listeria-immune cytotoxic T-cells is derived from LLO (Vijh and Pamer, 1997). Perhaps the fail-safe properties of LLO that are necessary for pathogenesis, such as rapid degradation in the cytosol, also lead to entry of LLO into the host's cytosolic pathway of antigen processing and presentation. Thus, LLO lies at the interface of bacterial pathogenesis and cell-mediated immunity.
We thank Laurel Lenz, Mary O'Riordan, and Matt Welch for critical reading of the review, and Darren Higgins for Fig. 1.
This work was supported by National Institutes of Health grants AI27655 and AI29619 (D.A. Portnoy).
↵* Abbreviations used in this paper: CDC, cholesterol-dependent cytolysin; EVH, Ena/VASP homology; LLO, listeriolysin O; PFO, perfringolysin O; PLC, phospholipase C; Mena, mouse Ena; Ena/VASP, enabled/vasodilator-stimulated phosphoprotein.
- Submitted: 3 May 2002
- Revision received 31 May 2002
- Accepted: 10 June 2002